Anders Wimo
Division of Geriatric Epidemiology (Sector of Health Economy)
Neurotec
Karolinska Institute
Huddinge
Sweden
Name/email consistency: high
- Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease. Wimo, A., Winblad, B., Stöffler, A., Wirth, Y., Möbius, H.J. Pharmacoeconomics (2003)
- Pharmacoeconomic aspects of memantine (Ebixa(R)) in the treatment of Alzheimer's disease. Wimo, A. Expert. Rev. Pharmacoecon. Outcomes. Res (2003)